SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-14-000028
Filing Date
2014-02-24
Accepted
2014-02-24 18:09:09
Documents
1
Period of Report
2014-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6391
  Complete submission text file 0001192482-14-000028.txt   8057
Mailing Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355
Business Address 7 GREAT VALLEY PARKWAY SUITE 300 MALVERN PA 19355 610-232-0800
NUPATHE INC. (Issuer) CIK: 0001375200 (see all company filings)

IRS No.: 202218246 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Reporting) CIK: 0001497725 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34836 | Film No.: 14638250